NFA
SIOX

Nationwide Fund Advisors’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Nationwide Fund Advisors’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-6,511
Closed -$358K – 2388
2017
Q3 		$358K Buy
6,511
+526
+9% +$88.7K ﹤0.01% 2350
2017
Q2 		$1.11M Sell
5,985
-4,458
-43% -$781K ﹤0.01% 1722
2017
Q1 		$1.25M Buy
10,443
+4,332
+71% +$454K 0.01% 1628
2016
Q4 		$607K Buy
6,111
+77
+1% +$8.11K ﹤0.01% 2072
2016
Q3 		$676K Sell
6,034
-157
-3% -$18.8K ﹤0.01% 2011
2016
Q2 		$636K Buy
6,191
+798
+15% +$79.8K ﹤0.01% 2016
2016
Q1 		$495K Sell
5,393
-205
-4% -$21.9K ﹤0.01% 2097
2015
Q4 		$807K Buy
5,598
+5,195
+1,289% +$676K ﹤0.01% 1835
2015
Q3 		$42K Buy
+403
New +$47.3K ﹤0.01% 3048

Other funds holding SIOX

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
IA
IPL Advisers New York $158M AUM 18.16% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IPLA
Ice Pond Lane Advisers New York $7.38M AUM 1.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Nationwide Fund Advisors's SIOX Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q4 2017, closing a stake of 6,511 shares — an estimated $358K sold.

Nationwide Fund Advisors first reported a position in SIOX in Q3 2015 and held it in 9 quarters. The position peaked at $1.25M in Q1 2017. 104 funds tracked by Wall St. Rank hold SIOX as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 6,511 Sio Gene Therapies Inc. Common Stock shares in Q4 2017, an estimated $358K.
  • Nationwide Fund Advisors first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2015 and held it in 9 quarters.
  • Nationwide Fund Advisors's Sio Gene Therapies Inc. Common Stock position peaked at $1.25M in Q1 2017.
  • 104 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.